IDEX Corporation provided earnings guidance for the second quarter and full year 2022. Full year 2022 organic sales growth is projected to be 6% to 8%, with an 8% to 9% organic sales increase in the second quarter of 2022 versus the prior year period. The company expected full year 2022 reported EPS attributable to IDEX of $6.87 to $7.00 and second quarter 2022 reported EPS attributable to IDEX of $1.69 to $1.74.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
215.2 USD | -0.18% | -3.23% | -0.90% |
05-16 | IDEX Biometrics Completes Upsized NOK55 Million Share Placement | MT |
05-08 | Declaration of Voting Results by IDEX Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.90% | 16.29B | |
-6.09% | 13.78B | |
+20.11% | 6.52B | |
-6.34% | 5.1B | |
+1.35% | 4.51B | |
+7.28% | 3.13B | |
+31.76% | 1.91B | |
+84.87% | 1.57B | |
+17.17% | 1B | |
-6.33% | 872M |
- Stock Market
- Equities
- IEX Stock
- News IDEX Corporation
- IDEX Corporation Provides Earnings Guidance for the Second Quarter and Full Year 2022